Squeezing life into botulinum toxin A in migraine: Imploding versus Exploding Pain

Pain

Volumn 125, Issue 3, 2006, Pages 206-207

  Goadsby, Peter J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANALGESIC AGENT; BOTULINUM TOXIN A;

ACETYLCHOLINE RELEASE; CLINICAL OBSERVATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG TREATMENT FAILURE; EDITORIAL; HEADACHE; HUMAN; MIGRAINE; NONHUMAN; OPEN STUDY; PAIN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; TENSION HEADACHE; TREATMENT OUTCOME; TREATMENT RESPONSE;

BOTULINUM TOXIN TYPE A; HUMANS; MIGRAINE DISORDERS; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 33750720042     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.10.001     Document Type: Editorial

References (18)

1. Aoki K.R. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26 (2005) 785-793
2. Brin M.F., Swope D.M., O'Brien C., Abbasi S., and Pgoda J.M. Botox for migraine: double-blind, placebo-controlled, region-specific evaluation. Cephalalgia 20 (2000) 421-422
3. Chankrachang S., Arayawichanont A., and Poungvarin N. Botulinum toxin type A in migraine without aura prophylaxis:a 12 week prospective, multicentre, double-blin, randomized, placebo-controlled trial. Cephalalgia 25 (2005) 992-993
4. Cui M., Khanijou S., Rubino J., and Aoki K.R. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107 (2004) 125-133
5. Dodick D.W., Mauskop A., Elkind A.H., DeGryse R., Brin M.F., and Silberstein S.D. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45 (2005) 315-324
6. Evers S., Rahmann A., Vollmer-Haase J., and Husstedt I.-W. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia 22 (2002) 699-710
7. Evers S., Vollmer-Haase J., Schwaag S., Rahmann A., Husstedt I.W., and Frese A. Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study. Cephalalgia 24 (2004) 838-843
8. Headache Classification Committee of The International Headache Society, The International Classification of Headache Disorders. 2nd ed. Cephalalgia, 2004;24:1-160.
9. Jakubowski M., McAllister P.J., Bajwa Z.H., Ward T.N., Smith P., and Burstein R. Exploding vs imploding headache in migraine prophylaxis with Botulinum toxin A. Pain 125 (2006) 286-295
10. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiat 75 (2004) 951-957
11. Mathew N.T., Frishberg B.M., Gawel M., Dimitrova R., Gibson J., and Turkel C. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45 (2005) 293-307
12. Olesen J., Bousser M.G., Diener H.C., Dodick D., First M., Goadsby P., et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26 (2006) 742-746
13. Relja M., Poole A.C., Schoenen J., Pascual J., Saulay M., and Kumar C. A multicentre, double-blind, randomised, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of migraine headaches. J Neurol 252 (2005) II-62
14. Saper J.R., Mathew N.T., Loder E.W., DeGryse R., and VanDenburgh A.M. A double-blind, randomised, placebo-controlled exploratory study comparing injection sites with low doses of botulinum toxin type A in the prevention of episodic migraine. J Neurol 252 (2005) II-58
15. Silberstein S, Mathew N, Saper J, Jenkins S, T.B.M.C.R.G. Botulinum toxin type A as a migraine preventive treatment. Headache 2000;40:445-50.
16. Silberstein S.D., Göbel H., Jensen R., Elkind A.H., DeGryse R., Walcott J.M.C.M., and Turkel C. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 26 (2006) 790-800
17. Silberstein S.D., Stark S.R., Lucas S.M., Christie S.N., Degryse R.E., and Turkel C.C. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 80 (2005) 1126-1137
18. Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33 (1981) 155-188